Results 211 to 220 of about 3,323,629 (269)

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial. [PDF]

open access: yesProstate Cancer Prostatic Dis
Trinh QD   +11 more
europepmc   +1 more source

Cost-effectiveness of an artificial intelligence predictive model for guiding androgen deprivation therapy in intermediate-risk prostate cancer. [PDF]

open access: yesJNCI Cancer Spectr
Courtney PT   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy